– USA, CA – Tetra Tech, Inc. (NASDAQ: TTEK) announced today that the Board of Directors has elected Kimberly E. Ritrievi to serve as a new director. Tetra Tech’s Board now totals nine members and includes eight outside directors.
Dr. Ritrievi is currently President of The Ritrievi Group LLC where she has advised technology and chemical companies on financial strategies. From 2001 to 2004 she served as Co-Director of Americas Investment Research at Goldman, Sachs & Co. Prior to that she was a Specialty Chemicals Analyst at Goldman, Sachs & Co., Credit Suisse First Boston, Lehman Brothers and Paine Webber (now UBS Wealth Management). Dr. Ritrievi started her career as a process development engineer at ARCO Chemical. She received her doctorate in Chemical Engineering from the Massachusetts Institute of Technology (MIT), and holds a master’s degree in Management from the MIT Sloan School of Management. Dr. Ritrievi continues to serve on advisory boards at Princeton University, Harvard University, and MIT.
Tetra Tech’s Chairman and CEO, Dan Batrack said, “We are pleased to welcome Dr. Ritrievi to our Board of Directors. Kim brings more than 25 years of experience in financial analysis, and a technical and educational background that enables her to make significant contributions to the Company’s strategy. We look forward to working with her on the Board.”
About Tetra Tech
Tetra Tech is a leading provider of consulting, engineering, program management, construction management, and technical services. The Company supports government and commercial clients by providing innovative solutions to complex problems focused on water, environment, energy, infrastructure, and natural resources. With more than 14,000 staff worldwide, Tetra Tech’s capabilities span the entire project life cycle.
For more information, visit www.tetratech.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
